Changes of complement and oxidative stress parameters in patients with acute cerebral infarction or cerebral hemorrhage and the clinical significance

Zheng,Mei; Wang,Xiaoyan; Yang,Jian; Ma,Song; Wei,Yi; Liu,Suping

doi:10.3892/etm.2019.8229

Changes of complement and oxidative stress parameters in patients with acute cerebral infarction or cerebral hemorrhage and the clinical significance

Authors:
- Mei Zheng
- Xiaoyan Wang
- Jian Yang
- Song Ma
- Yi Wei
- Suping Liu
View Affiliations

Affiliations: Ward Department, The People's Hospital of Zhangqiu Area, Jinan, Shandong 250200, P.R. China, Rehabilitation Department, Jinan Zhangqiu District Hospital of TCM, Jinan, Shandong 250200, P.R. China, Department of Clinical Laboratory, The People's Hospital of Zhangqiu Area, Jinan, Shandong 250200, P.R. China, Department of Orthopedics, The People's Hospital of Zhangqiu Area, Jinan, Shandong 250200, P.R. China, Hemodialysis Department, The People's Hospital of Zhangqiu Area, Jinan, Shandong 250200, P.R. China, Rehabilitation Department, Weifang People's Hospital, Weifang, Shandong 261041, P.R. China
Published online on: November 21, 2019 https://doi.org/10.3892/etm.2019.8229
Pages: 703-709
Copyright: © Zheng et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Changes of complement and oxidative stress parameters in patients with acute cerebral infarction (ACI) or cerebral hemorrhage (CH), and their clinical significance were explored. A total of 122 patients with ACI or CH admitted to the People's Hospital of Zhangqiu Area from August 2018 to September 2019 were collected. There were 59 ACI patients assigned into a cerebral infarction group (CIG) and further 63 CH patients in a cerebral hemorrhage group (CHG). Additionally, 53 healthy people in physical examination during the same period were enrolled as a control group (CG). Both the CIG and the CHG were treated with edaravone, Xueshuantong, brain protein hydrolysates, aspirin and statin‑related drugs. The levels of complement C3, complement C4, superoxide dismutase (SOD), and total antioxidant capacity (TAC) were determined. Receiver operating characteristic (ROC) curves were employed to analyze the predictive value of C3, C4, SOD and TAG in ACI and CH, and logistic regression was used to analyze the risk factors of stroke. Both CIG and CHG showed higher C3 level, and lower C4, SOD and TAC levels than the CG. The NIHSS <4 group and the NIHSS ≥4 group showed higher hs‑C3 level, and lower SOD and TAC levels than the CG (all P<0.05), and the NIHSS <4 group showed lower C3 level and lower SOD and TAC levels than the NIHSS ≥4 group (all P<0.05). Hypertension and hyperlipidemia were independent risk factors of stroke. The serum complement and oxidative stress parameters in patients with ACI or CH can be determined through routine examination, and the nerve function deficit could be assessed by determining the complement and oxidative stress parameters in clinical practice.

View Figures

View References

1	Feigin VL, Norrving B and Mensah GA: Global burden of stroke. Circ Res. 120:439–448. 2017. View Article : Google Scholar : PubMed/NCBI
2	Nogueira RG, Jadhav AP, Haussen DC, Bonafe A, Budzik RF, Bhuva P, Yavagal DR, Ribo M, Cognard C, Hanel RA, et al DAWN Trial Investigators, : Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. N Engl J Med. 378:11–21. 2018. View Article : Google Scholar : PubMed/NCBI
3	Keep RF, Andjelkovic AV, Xiang J, Stamatovic SM, Antonetti DA, Hua Y and Xi G: Brain endothelial cell junctions after cerebral hemorrhage: Changes, mechanisms and therapeutic targets. J Cereb Blood Flow Metab. 38:1255–1275. 2018. View Article : Google Scholar : PubMed/NCBI
4	An SJ, Kim TJ and Yoon BW: Epidemiology, risk factors, and clinical features of intracerebral hemorrhage: An update. J Stroke. 19:3–10. 2017. View Article : Google Scholar : PubMed/NCBI
5	Lai M, Wang D, Lin Z and Zhang Y: Small molecule copper and its relative metabolites in serum of cerebral ischemic stroke patients. J Stroke Cerebrovasc Dis. 25:214–219. 2016. View Article : Google Scholar : PubMed/NCBI
6	Wang W, Gao C, Yu C, Liu S, Hou D, Wang Y, Wang C, Mo L and Wu J: No association between elevated total homocysteine levels and functional outcome in elderly patients with acute cerebral infarction. Front Aging Neurosci. 9:702017. View Article : Google Scholar : PubMed/NCBI
7	Fanning JP, See Hoe LE, Passmore MR, Barnett AG, Rolfe BE, Millar JE, Wesley AJ, Suen J and Fraser JF: Differential immunological profiles herald magnetic resonance imaging-defined perioperative cerebral infarction. Ther Adv Neurol Disorder. Mar 13–2018.(Epub ahead of print). doi: 10.1177/1756286418759493. View Article : Google Scholar
8	Ono H, Nishijima Y, Ohta S, Sakamoto M, Kinone K, Horikosi T, Tamaki M, Takeshita H, Futatuki T, Ohishi W, et al: Hydrogen gas inhalation treatment in acute cerebral infarction: A randomized controlled clinical study on safety and neuroprotection. J Stroke Cerebrovasc Dis. 26:2587–2594. 2017. View Article : Google Scholar : PubMed/NCBI
9	Aronowski J and Zhao X: Molecular pathophysiology of cerebral hemorrhage: Secondary brain injury. Stroke. 42:1781–1786. 2011. View Article : Google Scholar : PubMed/NCBI
10	Lattanzi S, Brigo F, Trinka E, Cagnetti C, Di Napoli M and Silvestrini M: Neutrophil-to-lymphocyte ratio in acute cerebral hemorrhage: A system review. Transl Stroke Res. 10:137–145. 2019. View Article : Google Scholar : PubMed/NCBI
11	Bravata DM, Sico J, Vaz Fragoso CA, Miech EJ, Matthias MS, Lampert R, Williams LS, Concato J, Ivan CS, Fleck JD, et al: Diagnosing and treating sleep apnea in patients with acute cerebrovascular disease. J Am Heart Assoc. 7:e0088412018. View Article : Google Scholar : PubMed/NCBI
12	Qu S and Guo J: Clinical significance and difference of some biochemical indexes in patients with cerebral infarction and cerebral hemorrhage. Xiandai Jianyan Yixue Zazhi. 33:114–117. 2018.(In Chinese).
13	Qi FM, Yuan X and Dong Y: Analysis of SOD and HCY in acute cerebral infarction and acute cerebral hemorrhage patients. Int J Lab Med. 10:1323–1324. 2015.(In Chinese).
14	Zhou J and Zhang J: Identification of miRNA-21 and miRNA-24 in plasma as potential early stage markers of acute cerebral infarction. Mol Med Rep. 10:971–976. 2014. View Article : Google Scholar : PubMed/NCBI
15	Lin Z, Lin H, Li W, Huang Y and Dai H: Complement component C3 promotes cerebral ischemia/reperfusion injury mediated by TLR2/NFκB activation in diabetic mice. Neurochem Res. 43:1599–1607. 2018. View Article : Google Scholar : PubMed/NCBI
16	Simats A, García-Berrocoso T and Montaner J: Neuroinflammatory biomarkers: From stroke diagnosis and prognosis to therapy. Biochim Biophys Acta. 1862:411–424. 2016. View Article : Google Scholar : PubMed/NCBI
17	Anrather J and Iadecola C: Inflammation and stroke: An overview. Neurotherapeutics. 13:661–670. 2016. View Article : Google Scholar : PubMed/NCBI
18	Ighodaro OM and Akinloye OA: First line defence antioxidants-superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPX): Their fundamental role in the entire antioxidant defence grid. Alexandria J Med. 54:287–293. 2018. View Article : Google Scholar
19	Gonullu H, Aslan M, Karadas S, Kati C, Duran L, Milanlioglu A, Aydin MN and Demir H: Serum prolidase enzyme activity and oxidative stress levels in patients with acute hemorrhagic stroke. Scand J Clin Lab Invest. 74:199–205. 2014. View Article : Google Scholar : PubMed/NCBI
20	Estevez AY, Stadler B and Erlichman JS: In-vitro analysis of catalase-, oxidase-and SOD-mimetic activity of commercially available and custom-synthesized cerium oxide nanoparticles and assessment of neuroprotective effects in a hippocampal brain slice model of ischemia. FASEB J. 31:693.5. 2017.
21	Llull L, Amaro S and Chamorro Á: Administration of uric acid in the emergency treatment of acute ischemic stroke. Curr Neurol Neurosci Rep. 16:42016. View Article : Google Scholar : PubMed/NCBI
22	Milanlioglu A, Aslan M, Ozkol H, Çilingir V, Nuri Aydın M and Karadas S: Serum antioxidant enzymes activities and oxidative stress levels in patients with acute ischemic stroke: Influence on neurological status and outcome. Wien Klin Wochenschr. 128:169–174. 2016. View Article : Google Scholar : PubMed/NCBI
23	Zhang X, Huang WJ and Yu ZG: Relationship between the hypersensitive C-reactive protein (hs-CRP) level and the prognosis of acute brainstem infarction. Cell Biochem Biophys. 72:107–110. 2015. View Article : Google Scholar : PubMed/NCBI
24	Lee JH, Kwon KY, Yoon SY, Kim HS and Lim CS: Characteristics of platelet indices, neutrophil-to-lymphocyte ratio and erythrocyte sedimentation rate compared with C reactive protein in patients with cerebral infarction: A retrospective analysis of comparing haematological parameters and C reactive protein. BMJ Open. 4:e0062752014. View Article : Google Scholar : PubMed/NCBI
25	Li W, Jin C, Vaidya A, Wu Y, Rexrode K, Zheng X, Gurol ME, Ma C, Wu S and Gao X: Blood pressure trajectories and the risk of intracerebral hemorrhage and cerebral infarction: A prospective study. Hypertension. 70:508–514. 2017. View Article : Google Scholar : PubMed/NCBI
26	Hsieh FI and Chiou HY: Stroke: Morbidity, risk factors, and care in Taiwan. J Stroke. 16:59–64. 2014. View Article : Google Scholar : PubMed/NCBI